Hemiretinal vein occlusion 12-month outcomes are unique with vascular endothelial growth factor inhibitors: data from the Fight Retinal Blindness! Registry

Home Research Research Publication Hemiretinal vein occlusion 12-month outcomes are unique with vascular endothelial growth factor inhibitors: data from the Fight Retinal Blindness! Registry

Hemiretinal vein occlusion 12-month outcomes are unique with vascular endothelial growth factor inhibitors: data from the Fight Retinal Blindness! Registry.

Hunt AR, Nguyen V, Arnold JJ, McAllister IL, Mehta H, Invernizzi A, Ponsioen T, Gabrielle PH, O’Toole L, Kusenda P, Alforja S, Barthelmes D, Gillies MC.

Br J Ophthalmol. 2023 Jun;107(6):842-848. doi: 10.1136/bjophthalmol-2021-320482. Epub 2022 Jan 25.

PMID: 35078771

Need any help?

If you would like to know more about us, or want to make an appointment, please don’t hesitate to get in touch.

(08) 9381 0777

carecentre@lei.org.au

Hemiretinal vein occlusion 12-month outcomes are unique with vascular endothelial growth factor inhibitors: data from the Fight Retinal Blindness! Registry

Need any help?

Request an appointment